While polypharmacy is sometimes necessary, it can often lead to adverse drug events, increased costs, and cognitive or functional impairment. This program reviews the risks of polypharmacy and provides tools to support clinicians in identifying and reducing problematic polypharmacy, particularly through deprescribing. Using a patient case, this program will explore practical steps to review, assess and safely taper medications, so that clinicians are equipped with actionable steps to optimize medication use in practice.
Medication, Medication Management, Screening & Prevention
Optimizing Medication Use: A Guide to Deprescribing
DURATION
30 min
PROFESSION
Physician
# OF CREDITS
0.5
ACCREDITATION
Mainpro+
EXPIRY DATE
2026-05-08
While polypharmacy is sometimes necessary, it can often lead to adverse drug events, increased costs, and cognitive or functional impairment. This program reviews the risks of polypharmacy and provides tools to support clinicians in identifying and reducing problematic polypharmacy, particularly through deprescribing. Using a patient case, this program will explore practical steps to review, assess and safely taper medications, so that clinicians are equipped with actionable steps to optimize medication use in practice.
Faculty
- Barbara Farrell, BScPhm, PharmD, FCSHP
- Robert Hauptman, BMSc, MD, MCFP
- Christine Palmay, MD, CCFP, FCFP
- Alan Kaplan, MD, CCFP(EM), FCFP, CPC(HC)
- Bilal Hatoum, BSc Pharm, RPh, APA, CDE
- Kristen Watt, RPh
Learning objectives
Upon completion of this continuing education program, participants will be better able to:
- Describe the potential consequences of polypharmacy
- Identify patients who may benefit from deprescribing one or more of their medications
- Implement appropriate strategies to deprescribe medication(s)
Accreditation
This self-learning program has been certified by the College of Family Physicians of Canada for up to 0.5 Mainpro+ credits.
Cert+ Program ID#: 203961
Cost of course:
Free